Paladin Labs
is a pharmaceutical company focused on developing, acquiring, in-licensing, marketing and distributing pharmaceutical products... Read morePaladin Labs
is a pharmaceutical company focused on developing, acquiring, in-licensing, marketing and distributing pharmaceutical products... Read more
06/1996
PublicSubsidiary of Endo Pharmaceuticals Inc.TMX Group - Toronto Stock ExchangePLB
- -
2834 NAICS listing
News
Mar 31, 2024
Medthority
Paladin Labs: Health Canada approval for Wakik (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients
Jan 25, 2024
Pharmabiz
Paladin Labs: Paladin Labs launches Xcopri in Canada for management of partialonset seizures in adults with epilepsy
Sep 12, 2023
Cision Canada
Press Release: Paladin Labs : Paladin Labs Announced Favourable CADTH Recommendation for XCOPRI (cenobamate tablets)
Jun 12, 2023
centralcharts
Press Release: Paladin Labs : C3i partners with Paladin Labs Inc. to offer Canadian clinicians a complimentary testing service to detect T315I mutation
Jan 17, 2022
Markets Insider
Paladin Labs: Paladin Labs Launches Xydalba In Canada - Quick Facts
Jun 09, 2021
FinanzNachrichten
Paladin Labs: Paladin Labs Says Wakix Approved In Canada For Cataplexy In Adult Patients With Narcolepsy
Jan 05, 2021
BioSpace
Paladin Labs: Radius Health Announces Commercial Agreement with Paladin Labs for Abaloparatide in Canada
Nov 02, 2020
MarketScreener
Paladin Labs: Isofol Medical : announces licensing agreement for Paladin Labs Inc. to commercialize arfolitixorin in Canada
Oct 22, 2020
Cision Canada
Press Release: Paladin Labs : Envarsus PA Once-daily Immunosuppressive Therapy for Kidney and Liver Transplant Patients is Now Reimbursed in Ontario, Quebec, Manitoba and Saskatchewan
Jul 31, 2019
The Pharma Letter
Paladin Labs: BRIEF-Paladin Labs to commercialize pracinostat in Canada
Paladin Labs Competitors
1
2
3
4
5
6